NEMLUVIO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0299-6220 -
Package NDC
0299-6220-10 -
Package NDC
0299-6220-15 -
Application number
BLA761390 -
SPL ID
df0e2be2-b6bd-40e5-9175-0c8e893433ea -
SPL set ID
e9229ef1-ac60-4c24-afb6-009d3c781687 -
UNII
GN465U8B72 -
RxCUI
2691325 -
RxCUI
2691328
What the source publishes
- Labeler
- Galderma Laboratories, L.P.
- Active ingredients
- nemolizumab-ilto
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NEMLUVIO",
"splId": "df0e2be2-b6bd-40e5-9175-0c8e893433ea",
"labels": [
{
"setId": "e9229ef1-ac60-4c24-afb6-009d3c781687",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9229ef1-ac60-4c24-afb6-009d3c781687",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9229ef1-ac60-4c24-afb6-009d3c781687"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Galderma Laboratories, L.P.",
"finished": true,
"packaging": [
{
"sample": true,
"description": "1 SYRINGE, GLASS in 1 CARTON (0299-6220-10) / 30 mg in 1 SYRINGE, GLASS",
"package_ndc": "0299-6220-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20240813"
},
{
"sample": false,
"description": "1 SYRINGE in 1 CARTON (0299-6220-15) / 30 mg in 1 SYRINGE",
"package_ndc": "0299-6220-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20240813"
}
],
"productId": "0299-6220_df0e2be2-b6bd-40e5-9175-0c8e893433ea",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "0299-6220",
"deaSchedule": null,
"genericName": "nemolizumab-ilto",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NEMOLIZUMAB",
"strength": "30 mg/100mg"
}
],
"applicationNumber": "BLA761390",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240813",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194121",
"N0000194122"
],
"unii": [
"GN465U8B72"
],
"rxcui": [
"2691325",
"2691328"
],
"spl_set_id": [
"e9229ef1-ac60-4c24-afb6-009d3c781687"
],
"pharm_class_epc": [
"Interleukin-31 Receptor alpha Antagonist [EPC]"
],
"pharm_class_moa": [
"Interleukin-31 Receptor alpha Antagonists [MoA]"
],
"manufacturer_name": [
"Galderma Laboratories, L.P."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0299-6220_df0e2be2-b6bd-40e5-9175-0c8e893433ea"